Amine Oxide Biocompatible Polymer for Protein Stability and Cell Culture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for stabilizing proteins, preventing non-specific adsorption in antigen-antibody reactions, and enhancing cell culture media for antibody production are inadequate, leading to instability, high costs, and safety risks.
Innovation Solution
A biocompatible polymer composition comprising a vinyl polymer with an amine oxide group and specific molecular weight, combined with a compound having an amphoteric ion structure, is used for protein stabilization, blocking, and as a cell culture medium additive, optimizing surface tension and osmotic pressure for improved stability and productivity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If biologically derived proteins (normal serum, bovine serum albumin, gelatin, skim milk) are used as blocking agents, then non-specific adsorption is prevented, but performance variation occurs and sensitizing effect on antigen-antibody reaction is insufficient
Solution Approach 1:
The patent changes the chemical parameters of blocking agents by using synthetic polymers with specific molecular weights and functional groups (amphoteric ion compounds with basic groups and acidic groups) instead of biological proteins. This parameter change eliminates batch-to-batch variation inherent in biological sources while maintaining effective blocking performance and enhancing sensitizing effect on antigen-antibody reactions.
2Productivity
If animal sera (fetal bovine serum) are used in cell culture media, then cell proliferation and antibody production are enhanced, but cost increases and safety risks (prion diseases, viral contamination) occur
Solution Approach 1:
The patent replaces expensive and hazardous animal sera with synthetic polymer compounds that are cheaper to produce, have defined shelf lives, and eliminate the risk of prion diseases and viral contamination. The synthetic amphoteric ion compounds and amine oxide polymers serve as safe alternatives that maintain cell proliferation and antibody production capabilities without the safety concerns of biological products.
Solution Approach 2:
The patent creates a chemically defined, inert culture environment using synthetic polymers with specific functional groups (amphoteric ion compounds, amine oxide groups) that provide necessary biological activities without introducing potential contaminants. This inert synthetic environment eliminates the harmful factors associated with animal-derived sera while maintaining productivity.
3Reliability
If conventional polymers (polyethylene glycol, phosphorylcholine polymers) are used as protein stabilizers, then some stability is achieved, but satisfactory retention rate and stable period are not provided for certain proteins
Solution Approach 1:
The patent uses composite polymer structures combining amphoteric ion compounds with basic functional groups and acidic functional groups in specific ratios. This composite approach creates a synergistic effect where the basic groups interact with acidic residues on proteins while acidic groups interact with basic residues, providing superior and longer-lasting protein stability compared to single-function polymers like polyethylene glycol or phosphorylcholine polymers.
4Manufacturing precision
If multiple reactions and refinements are performed in synthesizing copolymer monomers, then specific structure is achieved, but productivity decreases
Solution Approach 1:
The patent segments the synthesis process by first preparing monomers with desired functional groups, then performing simple copolymerization in one step. This segmentation avoids multiple complex reactions and refinements, achieving both structural precision and high productivity. The use of readily available monomers with built-in functional groups (amphoteric ion compounds, amine oxide-containing monomers) further simplifies the synthesis pathway.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The polymer composition effectively stabilizes proteins, enhances antigen-antibody reactions, and increases antibody productivity and cell activity, reducing costs and safety concerns in cell culture.
Implementation Method 1
The higher-order structure of proteins is maintained through non-covalent weak polar interaction such as van der Waals interaction, hydrogen bond, and electrostatic interaction within the polypeptide chain
Implementation Method 2
The higher-order structure of proteins is maintained through non-covalent weak polar interaction such as van der Waals interaction, hydrogen bond, and electrostatic interaction within the polypeptide chain
Implementation Method 3
The higher-order structure of proteins is maintained through non-covalent weak polar interaction such as van der Waals interaction, hydrogen bond, and electrostatic interaction within the polypeptide chain
Implementation Method 4
a surface tension of a 1% aqueous solution at 25° C. is 30 dyne/cm to 50 dyne/cm
Implementation Method 5
an osmotic pressure in the 1% aqueous solution is 1 mOsm/kg to 20 mOsm/kg
Data Source
AI summary
A biocompatible polymer composition having excellent handling properties that serves as a protein stabilizer having excellent protein stabilizing performance, a blocking agent having an excellent sensitizing effect, and a cell culture medium additive capable of culturing antibody-producing cells at excellent antibody productivity and cell activity is provided. Provided is a biocompatible polymer composition that contains a vinyl polymer (A) having an amine oxide group and a mass-average molecular weight of 5,000 or more and water, the surface tension of a 1% aqueous solution of which at 25° C. is 30-50 dyne/cm.